Bandaram Pharma PacktechBOM:524602 -7.06%50 EBITDA Margin % is 3.14% as of Mar. 2026, which is 56% below its 10-year median of 7.07. GuruFocus rates BOM:524602 with a GF Score™ of 50/100 and a GF Value™ of ₹35.79 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 390 Packaging & Containers companies, Bandaram Pharma Packtech ranks worse than 74.62% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Bandaram Pharma Packtech EBITDA Margin % Related Terms
Bandaram Pharma Packtech EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524602 vs SW, PKG, IP: EBITDA Margin % Comparison
For the Packaging & Containers subindustry, Bandaram Pharma Packtech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bandaram Pharma Packtech EBITDA Margin % vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Bandaram Pharma Packtech's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Bandaram Pharma Packtech's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bandaram Pharma Packtech (BOM:524602) has a EBITDA Margin % of 3.14% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bandaram Pharma Packtech and its competitors. This is 56% below median its historical median of 7.07. Over the past decade, Bandaram Pharma Packtech's EBITDA Margin % has ranged from 4.64 to 7.89. According to the industry distribution chart, Bandaram Pharma Packtech ranks #291 out of 390 companies in the Packaging & Containers industry, placing it in the top 74.6%.
Is Bandaram Pharma Packtech's EBITDA Margin % too high?
Bandaram Pharma Packtech's current EBITDA Margin % of 3.14% is 56% below median its 10-year median of 7.07. Over the past 10 years, this metric has ranged from a low of 4.64 to a high of 7.89. The Packaging & Containers industry median EBITDA Margin % is 9.60. Bandaram Pharma Packtech's value of 3.14% is 67.3% below this industry median. Based on the distribution chart, Bandaram Pharma Packtech ranks #291 out of 390 companies in the Packaging & Containers industry, which is below the industry midpoint. Overall, Bandaram Pharma Packtech has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bandaram Pharma Packtech's EBITDA Margin % compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Bandaram Pharma Packtech ranks #291 out of 390 companies for EBITDA Margin %. This places Bandaram Pharma Packtech in the lower half of its industry. The industry median EBITDA Margin % is 9.60. Bandaram Pharma Packtech's value of 3.14% is 67.3% below this benchmark. Historically, Bandaram Pharma Packtech's own EBITDA Margin % has ranged from 4.64 to 7.89 over the past decade. While the company's 10-year median is 7.07 vs. the industry median of 9.60, Bandaram Pharma Packtech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Packaging & Containers company?
The median EBITDA Margin % among Packaging & Containers companies is 9.60, based on 390 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bandaram Pharma Packtech's current EBITDA Margin % of 3.14% is 67.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bandaram Pharma Packtech and its competitors. For the Packaging & Containers industry, the median EBITDA Margin % is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bandaram Pharma Packtech's current EBITDA Margin % is 3.14%, which is 56% below median its own 10-year median of 7.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bandaram Pharma Packtech stock overvalued right now?
Based on GuruFocus' analysis, Bandaram Pharma Packtech (BOM:524602) is currently considered Possible Value Trap. The stock's GF Value™ is ₹35.79, compared to a current price of ₹23.30 — trading 34.9% below its estimated fair value. The current EBITDA Margin % is 3.14%, which is 56% below median its 10-year median of 7.07 and 67.3% below the Packaging & Containers industry median of 9.60. Bandaram Pharma Packtech's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Bandaram Pharma Packtech (BOM:524602), the current EBITDA Margin % is 3.14% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bandaram Pharma Packtech (BOM:524602) Overvalued in 2026?
Based on GuruFocus' analysis, Bandaram Pharma Packtech stock appears to be undervalued.
The current stock price of ₹23.30 is trading 34.9% below its estimated GF Value™ of ₹35.79.
GuruFocus considers Bandaram Pharma Packtech to be Possible Value Trap.
Key valuation signals for BOM:524602:
EBITDA Margin %: 3.14% (56% below median its 10-year median of 7.07)
GF Value™: ₹35.79 vs. price of ₹23.30 (34.9% below fair value)
Industry Position: 67.3% below the Packaging & Containers median (#291 of 390)
No single metric tells the full story. See the BOM:524602 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bandaram Pharma Packtech Ltd is an India-based company engaged in the manufacturing of paper products and packing materials with more focus on catering to the needs of the pharma, food, and beverages industry apart from undertaking logistics business. The company is engaged in the Trading of Paper boards and Recycled Waste Paper. The company has only one business segment procurement and supply of recycled paper.
50GF Score
Get the complete analysis for BOM:524602
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524602 has been successfully added to your 
